期刊文献+

6例应用硼替佐米患者引起外周神经病变的护理 被引量:5

下载PDF
导出
摘要 目的总结应对硼替佐米引起外周神经病变的有效护理措施以减少患者的痛苦。方法对6例多发性骨髓瘤患者使用硼替佐米后出现严重外周神经病变的护理过程进行回顾性分析总结。结果无1例发生护理并发症,1例外周神经病变的严重度4级降为2级,5例3级降为1级;2例神经疼痛NCI分级4级降为2级,3例3级为2级,1例3级为1级。结论积极的预防和护理能有效减轻硼替佐米引起的外周神经病变毒副反应,减轻患者的痛苦。
作者 沈静慧
出处 《齐齐哈尔医学院学报》 2010年第18期2980-2981,共2页 Journal of Qiqihar Medical University
  • 相关文献

参考文献1

二级参考文献7

  • 1SEZER O, HEIDER U, ZAVRSKI I, et al. RANK ligand and osteoprotegerin in myeloma bone disease [ J ]. Blood, 2003,101 ( 6 ) :2094-2098.
  • 2BOYLE W J, SIMONET W S, LACEY D L. Osteoclast differentiation and activation[ J]. Nature ,2003,423 (6937) :337-342.
  • 3MATTINGLY L H, GAULT R A, MURPHY W J. Use of systemic proteasome inhibition as an immune-modulating agent in disease [ J ]. Endocr Metab Immune Disord Drug Targets, 2007,7 ( 1 ) : 29- 34.
  • 4AGGARWAL R, GHOBRIAL I M, ROODMAN G D. Chemokines in multiple myeloma [ J ~. Exp Hematol, 2006, 34 ( 10 ) : 1289- 1295.
  • 5GIULIANI N, MORANDI F, TAGLIAFERRI S, et al. The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients [ J ]. Blood, 2007, 110( 1 ) :334-338.
  • 6NAITO A, AZUMA S, TANAKA S, et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-defieient mice[J ]. Genes Cells, 1999,4 (6) :353-362.
  • 7DOUGALL W, CHAISSON M. Monoclonal antibody targeting RANKL as a therapy for cancer-induced bone diseases [ J ]. Clin Calcium,2006,16(4) :627- 635.

共引文献5

同被引文献35

  • 1亢卉.硼替佐米在恶性血液病中的作用机制[J].中国新药与临床杂志,2006,25(6):459-462. 被引量:9
  • 2张良满,黄争艳,曾志英.硼替佐米治疗多发性骨髓瘤患者的护理[J].护理学杂志(综合版),2007,22(4):72-73. 被引量:9
  • 3陈灏珠.实用内科学(下册)[M].北京:人民卫生出版社,2005.1963.
  • 4Durie B G, Harousseau J L, Miguel J S, et al. International Uniform Response Criteria for Multiple Myeloma[J~ Leukemia, 2006, 20(9): 1467-1473.
  • 5Favis R, Sun Y, van de Velde H, et al. Genetic Variation Associated with Bortezomib-induced Peripheral Neuropathy [ J ]. Pharmacogenet Genomics, 2011, 21 (3): 121-129.
  • 6Cavaletti G, Gilardini A, Canta A, et al. Bortezomib induced Peripheral Neurotoxicity:A Neurophysiological and Patholog- ical Study in the Rat[ J ].Exp Neurol,2007,204(1):317-325.
  • 7Moreau P, Pylypenko H, Grosicki S, et al. Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma: A Randomised, Phase 3, Non-inferiority Study[ J ]. Lancet 0ncol,2011,12(5):431-440.
  • 8De Bettignies G,Coux O.Proteasome inhibitors:Dozens of molecules and still counting [J]. Bioehimie,2010,92(11):1530-1545.
  • 9Malhotra P,Choudhary P P,Lal V,et al.Prevalenee of peripheral neuropathy in multiple myeloma at initial diagnosis[J].Leuk Lymphoma,2012,52(11):2135-2138.
  • 10杜晓翔,张秀华,叶蕾,叶海格.硼替佐米联合大剂量地塞米松治疗多发性骨髓瘤的疗效与安全性[J].中国新药杂志,2008,17(14):1257-1260. 被引量:2

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部